1. Latest News
  2. Submit Press Release

Healthcare, Regulatory and Reimbursement Landscape – Denmark

This report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape.

Dec. 26, 2012 - PRLog -- The Danish healthcare market is showing healthy signs of recovery following the crippling global financial crisis of 2008, says the latest report from business intelligence providers GlobalData.

The firm’s new report* predicts Denmark’s pharmaceuticals sector to grow from US$4 billion in 2011 to US$7.3 billion by 2020, representing a Compound Annual Growth Rate (CAGR) of 6.9%. This expected growth follows three years of shrinking pharmaceutical revenue for the north European country.

Additionally, Denmark’s medical devices sector is forecast to grow from 2011’s total of US$1.4 billion, to US$2.3 billion by the end of the decade.

GlobalData attributes Denmark’s healthcare industry expansion to a growing elderly population: 16.8% of Danish citizens were 65 years old or older in 2011, with this proportion reaching 19.6% by 2020, according to Statistics Denmark.

Additionally, Denmark’s pharmaceutical market will be bolstered by investment in innovative products. Novo Nordisk, along with other Danish firms such as LEO Pharma and Lundbeck, invest 15%–20% of their revenues in R&D. Furthermore, the country’s biotechnology sector spent approximately US$5.2 billion on R&D in 2011 – the second highest in Europe.

For Sample Pages, please click or add the below link to your browser:


However, Denmark is not lacking in obstacles to overcome. At 25%, Value Added Tax (VAT) in the country is higher than that of other countries in the EU (UK and the

Netherlands have 20% and 19% respectively), and wages in Denmark are higher than

all other nations in the Organization for Economic Co-operation and Development (OECD), with the exception of Norway. Consequently, manufacturing and sales costs are substantial in Denmark.

This report is an essential source of information and analysis on Denmark`s healthcare, regulatory and reimbursement landscape.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.

GlobalData is a leading global business intelligence provider offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For further details, please click or add the below link to your browser:


Visit our report store:


For more details contact:pressreleases@globaldata.com

North America:          +1 646 395 5477

Europe:          +44 207 753 4299

         +44 1204 543 533
Asia Pacific:          +91 40 6616 6782

--- End ---

Click to Share

Contact Email:
***@globaldata.com Email Verified
Zip:EC4Y 0AN
Location:London, Greater - United Kingdom
Tags:Healthcare, Regulatory, Reimbursement Landscape, Pharmaceuticals_and_healthcare
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share